Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. Diaz JH. J Travel Med 2020 Mar 18. pii: 5809509. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Diaz JH. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J Travel Med 2020 Mar 18. pii: 5809509. doi: 10.1093.
PMID: 32186711